{"entity":"merck","id":"ent_merck","name":"Merck & Co.","from":"2025-11-08","to":"2026-11-08","page":"https://asof.is/record/merck/diff?from=2025-11-08&to=2026-11-08","summary":"Between 2025-11-08 and 2026-11-08, Merck & Co.'s record changed in 17 facts: 3 replaced (net income $17.12 billion → $18.25 billion; research and development $17.94 billion → $15.79 billion; revenue $64.17 billion → $65.01 billion), 7 added, 7 ended; 11 unchanged.","counts":{"changed":17,"added":7,"ended":7,"replaced":3,"unchanged":11,"skipped_posts":{"from":0,"to":0}},"by_predicate":[{"predicate":"cash_and_equivalents","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_net_income","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_research_and_development","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_revenue","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"shares_outstanding","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_assets","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_equity","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"net_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"research_and_development","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"revenue","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"ceo","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"cik","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"fiscal_year_end","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"headquarters","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"listed_on","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"registrant_name","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"sic_industry","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"state_of_incorporation","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"ticker","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"website","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"x_username","added":0,"ended":0,"replaced":0,"unchanged":1}],"added":[{"id":"clm_5760FE8DF5CC","predicate":"cash_and_equivalents","value":"9,550,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,550,000,000 United States dollar\", as of 2026-09-30. Claim clm_5760FE8DF5CC, https://asof.is/claim/clm_5760FE8DF5CC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_5760FE8DF5CC","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_BE2114005849","predicate":"quarterly_net_income","value":"5,065,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,065,000,000 United States dollar\", as of 2026-09-30. Claim clm_BE2114005849, https://asof.is/claim/clm_BE2114005849, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_BE2114005849","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_8D15B1B2A78D","predicate":"quarterly_research_and_development","value":"4,537,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,537,000,000 United States dollar\", as of 2026-09-30. Claim clm_8D15B1B2A78D, https://asof.is/claim/clm_8D15B1B2A78D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_8D15B1B2A78D","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_D93F566AE261","predicate":"quarterly_revenue","value":"18,085,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 18,085,000,000 United States dollar\", as of 2026-09-30. Claim clm_D93F566AE261, https://asof.is/claim/clm_D93F566AE261, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_D93F566AE261","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_B0FE93A73A8D","predicate":"shares_outstanding","value":"2,465,245,688 shares","valid_from":"2026-10-31","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,465,245,688 shares\", as of 2026-10-31. Claim clm_B0FE93A73A8D, https://asof.is/claim/clm_B0FE93A73A8D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_B0FE93A73A8D","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_700C48638C17","predicate":"total_assets","value":"132,773,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 132,773,000,000 United States dollar\", as of 2026-09-30. Claim clm_700C48638C17, https://asof.is/claim/clm_700C48638C17, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_700C48638C17","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_23DBC8C334E1","predicate":"total_equity","value":"44,893,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 44,893,000,000 United States dollar\", as of 2026-09-30. Claim clm_23DBC8C334E1, https://asof.is/claim/clm_23DBC8C334E1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_23DBC8C334E1","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-11-04"}}],"ended":[{"id":"clm_C86D1A2441BE","predicate":"cash_and_equivalents","value":"18,169,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 18,169,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_C86D1A2441BE, https://asof.is/claim/clm_C86D1A2441BE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_C86D1A2441BE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DB573F068746","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_44C6DC623BB5","predicate":"quarterly_net_income","value":"5,785,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,785,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_44C6DC623BB5, https://asof.is/claim/clm_44C6DC623BB5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_44C6DC623BB5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_052408C1DABC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_E7C205B81C1E","predicate":"quarterly_research_and_development","value":"4,234,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,234,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_E7C205B81C1E, https://asof.is/claim/clm_E7C205B81C1E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_E7C205B81C1E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CC42DDED77FE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_86C0BCF4E479","predicate":"quarterly_revenue","value":"17,276,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 17,276,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_86C0BCF4E479, https://asof.is/claim/clm_86C0BCF4E479, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_86C0BCF4E479","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A5059DD1C3C6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_216265EA32A0","predicate":"shares_outstanding","value":"2,482,022,536 shares","valid_from":"2025-10-31","valid_to":"2026-01-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,482,022,536 shares\", as of 2025-10-31 (until 2026-01-31). Claim clm_216265EA32A0, https://asof.is/claim/clm_216265EA32A0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_216265EA32A0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_816D1195758B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_7F62C5E7C6D5","predicate":"total_assets","value":"129,546,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 129,546,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_7F62C5E7C6D5, https://asof.is/claim/clm_7F62C5E7C6D5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_7F62C5E7C6D5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4A91E3E067AC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_BDAEC6471AF2","predicate":"total_equity","value":"51,850,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 51,850,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_BDAEC6471AF2, https://asof.is/claim/clm_BDAEC6471AF2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_BDAEC6471AF2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4011DB45C7C0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-11-05"}}],"replaced":[{"predicate":"net_income","from":{"id":"clm_C6B723CD22D3","predicate":"net_income","value":"17,117,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 17,117,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_C6B723CD22D3, https://asof.is/claim/clm_C6B723CD22D3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_C6B723CD22D3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_23107EF0C145","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-25"}},"to":{"id":"clm_23107EF0C145","predicate":"net_income","value":"18,254,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 18,254,000,000 United States dollar\", as of 2025-12-31. Claim clm_23107EF0C145, https://asof.is/claim/clm_23107EF0C145, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_23107EF0C145","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-24"}}},{"predicate":"research_and_development","from":{"id":"clm_B017880F2FAE","predicate":"research_and_development","value":"17,938,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 17,938,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_B017880F2FAE, https://asof.is/claim/clm_B017880F2FAE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_B017880F2FAE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_062934F11209","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-25"}},"to":{"id":"clm_062934F11209","predicate":"research_and_development","value":"15,789,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 15,789,000,000 United States dollar\", as of 2025-12-31. Claim clm_062934F11209, https://asof.is/claim/clm_062934F11209, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_062934F11209","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-24"}}},{"predicate":"revenue","from":{"id":"clm_B00A59ED1285","predicate":"revenue","value":"64,168,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 64,168,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_B00A59ED1285, https://asof.is/claim/clm_B00A59ED1285, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_B00A59ED1285","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E778C75FD821","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-25"}},"to":{"id":"clm_E778C75FD821","predicate":"revenue","value":"65,011,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 65,011,000,000 United States dollar\", as of 2025-12-31. Claim clm_E778C75FD821, https://asof.is/claim/clm_E778C75FD821, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_E778C75FD821","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-24"}}}],"rule":"Two states compared by claim id: in both, unchanged; only on to, added; only on from, ended. An ended and an added claim on one predicate are a replacement when the ended one points to the added (superseded_by), or the predicate has exactly one of each and the added begins the day the ended ends. Added rows are labelled for to, ended rows for from. Posts and Hugging Face repos are counted in skipped_posts, not listed.","legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}